Introduction {#s1}
============

Inter-bacterial conflict is ubiquitous in nature, particularly in the dense and highly competitive microenvironments of biofilms ([@bib17]; [@bib28]; [@bib72]). In these settings, bacteria must battle for space and nutrients while evading antagonism by neighboring cells. One strategy for managing these environments is for bacteria to cooperate with their kin cells, sharing secreted molecules as public goods ([@bib59]; [@bib1]). However, these public goods are vulnerable to exploitation by other species or by 'cheater' bacterial strains that benefit from public goods but do not contribute to their production. For this reason, many bacteria participate in both cooperative and antagonistic behaviors to survive in multispecies biofilms. Bacterial antagonistic factors can range from small molecules to large proteins, delivered directly or by diffusion, and can either act on a broad spectrum of bacterial taxa or narrowly target only a few species. Although narrowly targeted mechanisms may seem to be of less utility than those that enable antagonism against diverse bacterial competitors, targeted strategies can be critical for bacterial success because they tend to mediate competition between closely-related organisms that are most likely to overlap in their requirements for restricted nutrients and niches ([@bib38]).

The bacterium *Legionella pneumophila* (*Lp*) naturally inhabits nutrient-poor aquatic environments where it undergoes a bi-phasic lifestyle, alternating between replication in host eukaryotes and residence in multi-species biofilms ([@bib50]; [@bib20]; [@bib21]; [@bib82]). If *Lp* undergoes this lifecycle within man-made structures such as cooling towers, the bacteria can become aerosolized and cause outbreaks of a severe, pneumonia-like disease in humans, called Legionnaires' disease ([@bib29]; [@bib55]; [@bib26]). Because of the serious consequences of *Lp* colonization, the persistence and growth of *Legionella* in aquatic environments has been the subject of numerous studies. These studies have examined replication within protozoan hosts ([@bib74]; [@bib50]; [@bib40]), survival in water under nutrient stress ([@bib51]; [@bib56]), and sensitivity to biocides ([@bib46]; [@bib52]). Here, we focus on interbacterial competition as an underappreciated survival challenge for *Lp*.

*Legionella spp.* are not known to produce any antibiotics, bacteriocins, or other antibacterial toxins. Bioinformatic surveys of *Legionella* genomes have revealed a number of polyketide synthases and other loci that likely produce bioactive metabolites ([@bib43]; [@bib84]), but these have not been shown to exhibit any antimicrobial functions. Nevertheless, there are some hints that interbacterial competition is relevant for *Lp* success within biofilms. For example, one study of artificial two-species biofilms found that viable *Lp* were able to persist for over two weeks in the presence of some bacterial species (e.g. *Pseudomonas fluorescens, Klebsiella pneumoniae*) but not others (e.g. *Pseudomonas aeruginosa*) ([@bib81]). Additionally, *Lp* bacteria are often co-resident with other *Legionella spp.* in man-made structures, with some studies showing that *Lp* proliferation is correlated with a decrease in other *Legionella spp.* populations ([@bib86]; [@bib67]; [@bib20]). These studies suggest that *Lp* bacteria may compete with other *Legionella spp.* for similar biological niches.

The most direct evidence for interbacterial competition comes from [@bib80], who found that *Lp* could antagonize the growth of neighboring *Legionella spp.* on the same plate. The molecules mediating this competition have not been identified, although previous work suggested a role for *Lp*'s secreted surfactant, a thin liquid film that facilitates the spread of *Lp* across agar plates ([@bib79]; [@bib80]). Still, it remained unknown if surfactant played a direct or indirect role in inter-*Legionella* inhibition.

Here, we use unbiased genetic approaches to find that homogentisic acid (HGA) produced by *Lp* generates oxidative intermediates that inhibit the growth of neighboring *Legionella spp*. We find that HGA production co-occurs with surfactant production, but that these are independent, separable phenomena. The redox state of HGA appears to be critical for its activity, as HGA is only toxic in aerobic conditions and fully oxidized HGA-melanin pigment is inactive. Unexpectedly, we find that although *Lp* secretes abundant HGA, it is also susceptible to HGA-mediated inhibition. We identify one gene-- *lpg1681*-- that enhances *Lp* susceptibility to HGA. Moreover, we find that *Lp* cells are resistant to HGA at high-density, which is also when they secrete large amounts of HGA. This high-density resistance is cell intrinsic and is independent of growth phase, the stringent response, or the previously described quorum-sensing pathway in *Legionella*. Based on these findings, we propose that HGA has the potential to play an important role in structuring *Legionella* communities.

Results {#s2}
=======

*L. pneumophila* inhibits *L. micdadei* via an unknown, secreted inhibitor {#s2-1}
--------------------------------------------------------------------------

Inspired by previous reports ([@bib80]), we investigated how *Legionella pneumophila* (*Lp*) engages in inter-*Legionella* competition. We found that *Lp* inhibited the growth of neighboring *Legionella micdadei* (*Lm*) plated 1 cm away on solid media, suggesting that it produces a secreted inhibitor ([Figure 1A](#fig1){ref-type="fig"}). This inhibition was most robust when we plated the *Lp* strain on low-cysteine media 3--4 days prior to plating *Lm*, allowing time for the inhibitory molecule to be produced and spread across the plate. To quantify this inhibition, we recovered *Lm* grown at different distances from *Lp*. After 48 hr incubation, we found a 10,000-fold difference in growth between *Lm* antagonized by *Lp* versus *Lm* plated outside of the zone of inhibition ([Figure 1B](#fig1){ref-type="fig"}).

![*L. pneumophila (Lp)* produces a secreted inhibitor independent of surfactant.\
(**A**) When pre-incubated on low-cysteine BCYE charcoal agar plates, *Lp* produces a zone of inhibition, impacting the growth of nearby *L. micdadei (Lm)*. Arrows mark the edge of inhibition fronts. Droplets of *Lm* at different dilutions were added to the plate in parallel columns three days after streaking *Lp*. WT *Lp* (left panel) generates a similar zone of inhibition as a surfactant-null mutant, ∆*bbcB* (right panel). (**B**) Quanitification of *Lm* growth within ('near') or outside of ('far') the wild type *Lp* zone of inhibition. (**C**) Quanitification of *Lm* growth within or outside of the ∆*bbcB Lp* zone of inhibition. In B and C, bacteria were sampled and removed from the plate in a 'plug' of fixed area before plating for viable CFUs.](elife-46086-fig1){#fig1}

Previous studies ([@bib80]) had proposed that inter-*Legionella* inhibition could be caused by *Lp*'s secreted surfactant, which is produced by *Lp* but not *Lm* ([@bib79]). We tested this hypothesis by deleting a surfactant biosynthesis gene, *bbcB*, from the *Lp* genome ([@bib80]). The resulting *∆bbcB* strain did not produce surfactant ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}), yet it still inhibited adjacent *Lm* ([Figure 1A](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1C](#fig1s1){ref-type="fig"}). When quantified, we observed nearly identical inhibition from both wild type *Lp* and *∆bbcB Lp* ([Figure 1B and C](#fig1){ref-type="fig"}) indicating that the surfactant did not enhance inhibition. Furthermore, we observed that the zone of inhibition surrounding wildtype *Lp* did not always co-occur with the spread of the surfactant front ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). From these results, we conclude that *L. pneumophila* can cause strong growth inhibition of neighboring *Legionella* using an unknown molecule that is distinct from surfactant.

Transposon screen pinpoints HGA-melanin pathway in inter-*Legionella* inhibition {#s2-2}
--------------------------------------------------------------------------------

To determine which molecule(s) might be responsible for inter-*Legionella* inhibition, we performed an unbiased genetic screen in *Lp*. We generated *Lp* mutants using a drug-marked Mariner transposon that randomly and efficiently integrates into the *Legionella* genome ([@bib64]). To identify mutants that were defective in producing the inhibitor, we transferred each mutant onto a lawn of *L. micdadei* on low-cysteine plates and examined the resulting zone of inhibition surrounding each *Lp* mutant ([Figure 2A](#fig2){ref-type="fig"}). After screening 2870 clones, we isolated 19 mutants that produced a smaller zone of inhibition than wild type *Lp*, as well as five mutants that showed a complete loss of inhibition ([Figure 2B](#fig2){ref-type="fig"}, [Supplementary file 1](#supp1){ref-type="supplementary-material"}). We refer to these as 'small zone' and 'no zone' mutants, respectively. Among the 'small zone' mutants, some had defects in surfactant spreading on plates, while others showed enhanced surfactant spread ([Figure 2---figure supplement 1A](#fig2s1){ref-type="fig"}), further distinguishing inter-bacterial inhibition from surfactant secretion.

![Transposon mutagenesis screen implicates the HGA-melanin pathway in production of the inhibitor.\
(**A**) Screen for mutant *L. pneumophila* (*Lp)* that do not inhibit *L. micdadei* (*Lm*). Following electroporation of a Mariner-transposon-containing plasmid, *Lp* mutants were selected for transposon integration. Colonies were patched or replica plated onto a lawn of *Lm*. Mutants of interest generated a zone of inhibition that was reduced (black arrowhead) or absent (pink arrowhead) compared to WT *Lp*. (**B**) Selected transposon mutants produce abnormal zones of inhibition when grown on a lawn of *Lm*. Pink arrowhead indicates a *hisC2*::Tn 'no zone' mutant. (**C**) Transposon insertion sites (triangles) identified in the five recovered 'no zone' mutants. (**D**) HGA-melanin synthesis pathway. HGA is exported from the cell where it auto-oxidizes and polymerizes to form HGA-melanin. Genes in pink were validated by complementation to have essential roles in *Lm* inhibition.](elife-46086-fig2){#fig2}

We focused on the 'no zone' mutants, as these had the strongest defects in inhibition. These five mutants carried transposon insertions in two separate operons ([Figure 2C](#fig2){ref-type="fig"}). The first operon had two insertions in the *hisC2* gene (*lpg1998)*, which breaks down tyrosine as part of the HGA-melanin metabolic pathway ([Figure 2D](#fig2){ref-type="fig"}). Its downstream gene, *pphA*, converts phenylalanine to tyrosine in the same pathway. To validate the role of *hisC2* in inhibition, we overexpressed this gene in the *hisC2* transposon mutant background and found that *hisC2* alone was sufficient to complement the mutant phenotype ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). Having confirmed the role of *hisC2*, we turned to the second operon, where we had recovered transposon insertions in two uncharacterized genes, *lpg2276* and *lpg2277* ([Figure 2C](#fig2){ref-type="fig"}). These two genes lie immediately upstream of *hpd* (*lpg2278*), which is known to act with *hisC2* in the HGA-melanin pathway ([@bib78]; [@bib31]) ([Figure 2D](#fig2){ref-type="fig"}). Because transposon insertions at the beginning of an operon can disrupt the expression of downstream genes via polar effects, we hypothesized that the insertions we recovered in *lpg2276* and *lpg2277* altered inter-*Legionella* inhibition via disruption of *hpd* expression. Indeed, we were able to complement insertions in both genes, which had yielded 'no zone' mutants, by overexpressing *hpd,* despite the fact that *hpd* overexpression caused a growth defect ([Figure 2---figure supplement 1B](#fig2s1){ref-type="fig"}). In conclusion, all five 'no zone' isolates had mutations that disrupted the same metabolic pathway involved in the production of HGA-melanin. Consistent with these findings, we observed defects in HGA-melanin pigmentation in all of the 'no zone' mutants as well as some of the 'small zone' mutants ([Figure 2---figure supplement 1E](#fig2s1){ref-type="fig"}).

The HGA-melanin pathway is found in diverse eukaryotes and bacteria ([@bib63]; [@bib53]) including *Legionella spp.* ([@bib24]) ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}). This pathway produces homogentisic acid (HGA) from the catabolism of phenylalanine or tyrosine ([@bib78]) ([Figure 2D](#fig2){ref-type="fig"}). HGA can either be further metabolized and recycled within the cell via HmgA-C, or it can be secreted outside of the cell, where it auto-oxidizes and polymerizes to form a black-brown pigment called HGA-melanin, or pyomelanin ([@bib47]) ([Figure 2D](#fig2){ref-type="fig"}). To test whether intracellular metabolites downstream of HGA are necessary for inhibition, we deleted *hmgA*, the first gene in the pathway that recycles HGA back into central metabolism. We found that the ∆*hmgA* strain produced a zone of inhibition that was similar or slightly larger than wild type ([Figure 2---figure supplement 1C](#fig2s1){ref-type="fig"}). We therefore inferred that synthesis of secreted HGA and/or HGA-melanin, but not its recycling and intracellular processing, is required for *Lp* inhibition of *Lm.*

HGA inhibits the growth of *Legionella micdadei*, but HGA-melanin does not {#s2-3}
--------------------------------------------------------------------------

To our knowledge, the HGA-melanin pathway has not previously been implicated in inter-bacterial competition. To the contrary, prior work has emphasized the beneficial (rather than detrimental) effects of HGA-melanin on *Legionella* growth, by providing improved iron scavenging ([@bib11]) and protection from light ([@bib77]). We therefore asked whether the active inhibitor produced by the pathway was HGA-melanin, or alternatively a precursor molecule ([Figure 3A](#fig3){ref-type="fig"}). We tested the potential inhibitory activity of HGA-melanin pigment from *Lp* conditioned media in multiple experiments; however, we never observed any inhibition of *Lm*. We wished to rule out the possibility that the pigment secreted into rich media was too dilute to be active, or that other nutrients in the media might interfere with inhibition. We therefore isolated a crude extract of HGA-melanin from *Lp* conditioned media via acid precipitation (as in [@bib11]), washed and concentrated the pigment approximately 10-fold and repeated the assay; the concentrated pigment also showed no inhibitory activity ([Figure 3B and E](#fig3){ref-type="fig"}).

![Synthetic HGA inhibits *Legionella micdadei* growth, depending on its oxidation state.\
(**A**) We tested whether inter-bacterial inhibition is caused by HGA, HGA-melanin, or an oxidative intermediate. (**B**) Zones of inhibition on a lawn of *Lm* generated from either live *Lp* bacteria, synthetic 50 mM HGA, or concentrated pigment extract. HGA prevents *Lm* growth in a large region (central dark circle) but pigment does not. (**C**) Growth inhibition of *Lm* from increasing concentrations of synthetic HGA in rich AYE media. (**D**) Pre-oxidation of synthetic HGA in AYE media for 24 hr eliminates its inhibitory activity, resulting in normal *Lm* growth. Concentrations of HGA colored as in panel C. (**E**) Addition of oxidized HGA-melanin pigment from *Lp* has little impact on *Lm* growth in AYE liquid media. (**F**) In the absence of HGA (gray symbols), titration of L-cysteine (L-cys) from 25--200% of standard AYE media has little impact on *Lm* growth. In contrast, HGA activity is enhanced in low-cysteine media and decreased in high-cysteine media (green symbols). All error bars show standard deviations among 3--4 replicates.](elife-46086-fig3){#fig3}

The first metabolite secreted by the HGA-melanin pathway is HGA. We tested whether HGA could behave as an inhibitor even though HGA-melanin could not. Indeed, we found that synthetic HGA robustly inhibited *Lm* growth, both when spotted onto a lawn of *Lm* and when titrated into AYE rich media ([Figure 3B and C](#fig3){ref-type="fig"}), We found that inhibition of *Lm* by HGA is relatively specific at the molecular level; neither 2-hydroxyphenylacetic acid nor 3-hydroxyphenylacetic acid, two HGA-related molecules that differ from HGA by only a single -OH group, were able to inhibit *Lm* growth at any concentration tested ([Figure 3---figure supplement 1A](#fig3s1){ref-type="fig"}).

Because HGA, but not HGA-melanin, can inhibit *Lm* growth ([Figure 3B and E](#fig3){ref-type="fig"}), we inferred that the oxidative state of HGA might be important to its inhibitory activity. HGA is a reactive molecule, which auto-oxidizes ([@bib23]) and polymerizes to form HGA-melanin through a series of non-enzymatic steps that are not genetically encoded ([@bib78]) and are therefore undetectable by our genetic screen. Given its auto-oxidative potential, we next tested whether HGA might cause growth inhibition by oxidizing other nearby molecules, either in the media or on bacterial cells. We allowed synthetic HGA to oxidize completely for 24 hr in AYE media before adding *Lm* ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). We found that pre-oxidation completely abolished synthetic HGA activity, even at very high HGA concentrations ([Figure 3D](#fig3){ref-type="fig"}, compare to 3C). This experiment also ruled out the possibility that HGA acts by causing nutrient depletion or other modifications of the media, since media pre-incubated with HGA for 24 hr is still able to support normal *Lm* growth. Instead, we infer that *Lm* inhibition results from direct interactions between bacterial cells and either HGA itself or unstable, reactive intermediates produced during HGA oxidation.

Small, reactive, quinone-like molecules similar to HGA are known to react with oxygen to produce H~2~O~2~, which is broadly toxic to bacteria ([@bib35]). In such cases, extracellular catalase has been shown to protect bacteria against the toxic effects of H~2~O~2~ ([@bib35]; [@bib41]). To test if HGA toxicity occurs via a similar mechanism as H~2~O~2~, we asked if extracellular catalase was sufficient to protect *Lm* from HGA-mediated toxicity. Even at very high catalase concentrations, we found that catalase provided no protection from HGA ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), ruling out the production of extracellular H~2~O~2~ as a potential mechanism of action for HGA-mediated inhibition. We also considered the possibility that HGA as a weak acid could inhibit *Lm* indirectly by altering the local pH, but we observed that adding HGA at 1 mM into AYE media or PBS caused little to no change in pH.

Given that the redox state of HGA is critical for inhibition, we reasoned that it should be possible to modulate HGA activity by altering the redox state of the media using reducing agents. We accomplished this by titrating L-cysteine from 25% to 200% of the levels in standard AYE media. In the absence of HGA, these altered cysteine concentrations had little impact on *Lm* growth ([Figure 3F](#fig3){ref-type="fig"}, gray symbols). However, lower cysteine concentrations greatly sensitized *Lm* to HGA, while excess cysteine was completely protective ([Figure 3F](#fig3){ref-type="fig"}). These findings may help partially explain why HGA's inhibitory activity on *Legionella* has not been previously detected, as *Legionella* species are typically studied in cysteine-rich media. We found that synthetic HGA is readily able to react with cysteine in vitro ([Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}), presumably impacting the oxidation state of HGA. Moreover, incubation of HGA with two other reducing agents, DTT (dithiothreitol) or reduced glutathione, similarly quenched HGA's inhibitory activity ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}). From these experiments, we conclude that HGA is less potent in rich media because it reacts with excess cysteine (or other bystander molecules) before it can interact with *Lm*. In sum, these results implicate the reactive activity of HGA and/or its transient, oxidative intermediates in inter-*Legionella* inhibition.

In these experiments, synthetic HGA was a robust inhibitor of *Lm.* However, this inhibition required relatively high concentrations of HGA (\>50 µM). We next quantified the amount of HGA secreted by *Lp* to determine if these levels were biologically relevant. Compared to other *Legionella spp.*, *Lp* produces much more pigment ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}), suggesting that it secretes considerably more HGA. To estimate the quantity of secreted HGA, we created a standard curve of synthetic HGA in AYE rich media. We allowed the HGA added to completely oxidize to HGA-melanin, which can be measured by OD 400 readings. In this way, we can use the pigment levels after oxidation as a reliable measure of total HGA that was produced by a given time-point ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). Using this calibration, we estimated that wild type *Lp* had secreted the equivalent of 1.7 mM HGA after 48 hr of culture, whereas the hyperpigmented *∆hmgA* strain secreted about 2.6 mM HGA. Thus, the levels of HGA produced by *Lp* are considerably higher than the inhibitory concentrations of synthetic HGA used in our assays (50--500 µM), at least under lab conditions. In contrast, we did not detect any pigment from the non-inhibitory *hisC2*::Tn strain ([Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). From these experiments, we conclude that HGA is an abundant, secreted, redox-active metabolite of *Lp*, which can accumulate in concentrations that are relevant for inter-*Legionella* inhibition.

*L. pneumophila* can be susceptible to its own inhibitor {#s2-4}
--------------------------------------------------------

Our results so far indicated that HGA can be a potent, redox-active inhibitor of *Lm*, which is volatile and capable of reacting with many types of thiol-containing molecules. If *Lp* uses HGA to compete with neighboring *Legionella spp.*, we anticipated that *Lp* would have evolved some form of resistance to its own secreted inhibitor. Therefore, we next tested *Lp* susceptibility to inhibition in low-cysteine conditions, as we had previously done for *Lm*. Surprisingly, we found that *Lp* was quite sensitive to inhibition by neighboring *Lp* that was already growing on the plate ([Figure 4A](#fig4){ref-type="fig"}). Indeed, *Lp* susceptibility closely mirrored the susceptibility of *Lm* to inhibition (compare to [Figure 1A](#fig1){ref-type="fig"}), even though the bacterial cells secreting the inhibitor were genetically identical to the inhibited *Lp*. In both cases, we observed a sharp boundary at the edge of the zone of inhibition. In contrast, the 'no zone' *Lp* strain *hisC2*::Tn did not generate a sharp zone of inhibition against neighboring *Lp* ([Figure 4A](#fig4){ref-type="fig"}), suggesting that the HGA-melanin pathway was responsible for both *Lm* and *Lp* inhibition. Furthermore, we found that synthetic HGA was able to inhibit *Lp* in liquid cultures at the same concentrations that were inhibitory to *Lm* (compare [Figures 4B](#fig4){ref-type="fig"} and [3C](#fig3){ref-type="fig"}).

![*L. pneumophila* is susceptible to bacteriostatic inhibition by HGA in rich media.\
(**A**) When pre-incubated on agar plates, *Lp* produces a zone of inhibition (arrows), preventing the growth of genetically-identical *Lp* plated 3 days later. The 'no zone' mutant *hisC2*::Tn does not produce a sharp front of inhibition, implicating HGA. (**B**) Increasing concentrations of synthetic HGA inhibit the growth of *Lp*, causing a growth delay in rich media. Error bars showing standard deviation are small and mostly obscured by the symbols. (**C**) To test if *Lp* population recovery at late time points following HGA exposure is due to the outgrowth of HGA-resistant mutants, we grew *Lp* with or without HGA and sampled bacteria at the end of the experiment (arrowhead) that were unexposed to HGA or were exposed to 250 µM HGA. These were used to inoculate media ± fresh HGA. (**D**) Prior HGA exposure did not lead to subsequent resistance. (**E**) The time for *Lp* to grow in the presence of HGA is correlated with the time for synthetic HGA to oxidize at each concentration, suggesting that *Lp* delays growth until HGA has sufficiently oxidized to lose inhibitory activity. Plot shows data combined across eight experiments. Linear fit curve and equation are shown.](elife-46086-fig4){#fig4}

However, our comparisons between *Lm* and *Lp* revealed one important difference in their response to HGA inhibition. Unlike *Lm,* the *Lp* cultures exposed to HGA exhibited a population rebound after a dose-dependent growth delay, measured by both OD600 and plating for viable CFUs ([Figure 4B](#fig4){ref-type="fig"}, [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). This rebound response was shared between the KS79 lab strain and the Philadelphia-1 original *Lp* strain ([Figure 4---figure supplement 1A](#fig4s1){ref-type="fig"}). We hypothesized that the *Lp* rebound response following HGA inhibition occurred because of selection and outgrowth of HGA-resistant mutants following exposure. To test this possibility, we collected 'post-rebound' stationary phase *Lp* previously exposed to 250 µM HGA and compared their subsequent HGA sensitivity to unexposed *Lp* ([Figure 4C--D](#fig4){ref-type="fig"}). We found that both cultures showed nearly identical susceptibility to HGA inhibition, suggesting that *Lp* population rebounds were not driven by genetic adaptation.

We therefore considered an alternate possibility that *Lp* populations exposed to HGA remain static until HGA levels fall below inhibitory concentrations, reflecting the auto-oxidation and loss of HGA activity over time. This possibility was supported by CFU measurements, which showed that HGA is bacteriostatic but not bacteriocidal against *Lp* during the growth delay ([Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). Furthermore, we observed a strong, linear correlation between the time required to fully oxidize a given concentration of HGA and the length of the growth delay induced by *Lp* ([Figure 4E](#fig4){ref-type="fig"}). Based on our multiple observations, we favor the parsimonious conclusion that synthetic HGA causes initial, bacteriostatic inhibition of *Lp* until it has been sufficiently oxidized and thereby inactivated, enabling *Lp* growth. We note that the liquid culture assays ([Figure 4B](#fig4){ref-type="fig"}) differ from the co-plating assays, in which we did not observe *Lp* rebound ([Figure 4A](#fig4){ref-type="fig"}). In the latter case, we presume that bacteria continually secrete fresh HGA to replace the oxidized HGA over time. Thus, our results confirm a surprising role for HGA in both interspecies and intraspecies *Legionella* inhibition.

Non-essential gene *lpg1681* sensitizes *L. pneumophila* to HGA {#s2-5}
---------------------------------------------------------------

We next investigated the molecular basis of *L. pneumophila* susceptibility and resistance to HGA using bacterial genetics. First, we tested the role of the HmgA-C proteins, which break down intracellular HGA and recycle it back into central metabolism. We hypothesized that HmgA-C proteins might also be able to deactivate extracellular HGA ([@bib73]) ([Figure 2D](#fig2){ref-type="fig"}). Contrary to this hypothesis, we found that the growth response of the *∆hmgA* mutant to increasing concentrations of synthetic HGA was nearly identical to that of wild type *Lp* ([Figure 4---figure supplement 1B](#fig4s1){ref-type="fig"}). These results suggest that the intracellular recycling pathway does not play an appreciable role in *Lp* resistance to extracellular HGA.

Having excluded the obvious candidate pathway for *Lp* resistance to HGA, we pursued an unbiased forward genetics approach. Because HGA is strongly inhibitory to low density bacteria, we performed a selection for spontaneous, HGA-resistant mutants of *Lp* and *Lm* using a high HGA concentration that normally prevents almost all growth for both species. To prevent HGA from reacting with media components and becoming inactive (as in [Figure 3D and F](#fig3){ref-type="fig"}), we mixed the bacteria with 1 mM HGA in agar overlays poured onto low-cysteine BCYE plates ([Figure 5A](#fig5){ref-type="fig"}). After six days, an average of 53 colonies had grown up on each *Lp* plate under HGA selection, whereas only 3--5 colonies grew on *Lm* plates exposed to HGA. Based on these results, we focused on HGA-selected mutants of *Lp*. We retested the phenotypes of spontaneous mutants on HGA +low cysteine plates and recovered 29 *Lp* strains that consistently grew better than wild type *Lp* ([Figure 5B](#fig5){ref-type="fig"}). Notably, all recovered mutants had a decrease in HGA sensitivity relative to wild type, but none were completely resistant. The spontaneous mutants also showed improved growth on low-cysteine plates, relative to wild type.

![*L.pneumophila* susceptibility to HGA is modulated by *lpg1681*.\
(**A**) Scheme to select for *Lp* spontaneous HGA-resistant mutants. (**B**) Growth of HGA-selected mutants (\*) compared to wild type *Lp*. All isolates grew better than wild type in selection conditions (HGA + low cysteine), as well as in low cysteine conditions. (**C**) Syntenic region of *lpg1681* in *Lp* strains. *Lpg1681* is a hypothetical gene that lies downstream of *lpg1682*, a predicted oxidoreductase/dehydrogenase, and upstream of *dsbD2*, a thiol:disulfide interchange protein. (**D**) In rich media, a spontaneous *lpg1681* mutant (*lpg1681\**) and the *lpg1681* deletion strain (∆*lpg1681*) are less sensitive to growth inhibition by HGA than wild type *Lp*, as seen by a shorter growth delay at each concentration of HGA. Overexpression of *lpg1681* (OE) heightens sensitivity to HGA (longer growth delay). Graphs here summarize experiments similar to those in [Figure 4B](#fig4){ref-type="fig"}. See [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"} for full data.](elife-46086-fig5){#fig5}

To determine the underlying genetic basis of these phenotypes, we sequenced the genomes of all 29 strains plus the starting, wildtype strain of *Lp* to a median depth of 118x and identified mutations genome-wide. Each mutant strain carried 1 to 3 unique point mutations relative to the starting strain, and most of these mutations were found only in a few shared loci ([Table 1](#table1){ref-type="table"}). The most abundant category of mutants was genes related to translation; 19 of 29 resistant *Lp* strains carried mutations in translation-related machinery, of which 17 carried mutations in either elongation factor P (*lpg0287*) or enzymes responsible for adding post-translational modifications to elongation factor P (*lpg0607* and *lpg0288*). Elongation factor P acts to re-start stalled ribosomes at polyproline tracts, and its post-translational modifications are essential for these functions ([@bib88]; [@bib61]; [@bib22]; [@bib54]). Based on the frequency of polyprolines in the *Lp* proteome, disruptions to elongation factor P function have the potential to impact the expression of about 33% of *Lp* proteins. The HGA resistance phenotypes we observed in these 17 *Lp* mutants could therefore result from either a large-scale shift in gene expression, or from the altered expression of specific susceptibility genes.
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###### Genes Mutated in HGA-Selected *L. pneumophila*

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Mutated locus   Function or product                            \# Spontaneous Mutants w/this mutation   Mutations recovered
  --------------- ---------------------------------------------- ---------------------------------------- -------------------------------------------------------------------------
  *lpg1681*       Hypothetical Protein                           4                                        R49K, R49S, R49G, T50K

  *lpg0288*       YjeK,\                                         11                                       W8S, Q9\*, L26G, K39\*, A50P, R101L, D196G, H215R, Q243K, I250F, Q294\*
                  2,3-beta-lysine aminomutase                                                             

  *lpg0607*       PoxA/YjeA/GenX,\                               5                                        W100\*, Q184L, A218V, Q258\*,\
                  Elongation factor P beta-lysine transferrase                                            1 bp deletion in S156

  *lpg0325*       RpS7 ribosomal 30S protein                     1                                        G100D

  *lpg0336*       RplP 50 s ribosomal protein                    1                                        G88R

  *lpg0287*       Elongation factor P                            1                                        Stop \> Q (70 AA Extension)

  *lpg0349*       SecY                                           3                                        N118K, Q132R, R369L

  *lpg2001*       SecD                                           2                                        V238F, A277G

  *lpg1504*       AceE pyruvate dehydrogenase                    1                                        P272C
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* =introduction of a stop codon.

Elongation factor P disruption has also been previously linked to the activation of the stringent response pathway ([@bib60]), which is important for coordinating a variety of stress responses in *Legionella,* including oxidative stress ([@bib58]; [@bib65]). We therefore tested if the stringent response pathway is involved in regulating HGA susceptibility or resistance. We assayed HGA susceptibility in mutant *Lp* strains with disruptions to *rpoS*, *letA*, *relA*, and *spoT*, which act early in the stringent response pathway to regulate and/or respond to the levels of the alarmone ppGpp ([Figure 7---figure supplement 1C](#fig7s1){ref-type="fig"}) ([@bib3]; [@bib33]; [@bib16]). We found that the HGA susceptibility of all these mutants was similar to that of wild type; furthermore, complementation with these genes did not alter HGA susceptibility ([Figure 7---figure supplement 1D](#fig7s1){ref-type="fig"}). Thus, we find no evidence of a role for the stringent response in HGA susceptibility or resistance. Instead, we propose that disruptions to elongation factor P result in pleiotropic translation defects that together lead to HGA resistance via still-unknown mechanisms. In addition to the translation-related mutants, we found five missense mutations in *secY* or *secD* (*lpg0349* and *lpg2001*), members of the Sec secretion apparatus that moves polypeptides across the cytosolic membrane; one mutation in *aceE* pyruvate dehydrogenase (*lpg1504*); and four mutations in a hypothetical gene, *lpg1681* ([Table 1](#table1){ref-type="table"}, [Figure 5C](#fig5){ref-type="fig"}). The Sec apparatus is involved in the secretion of many substrates and mutations to this machinery could also lead to extensive pleiotropic defects.

Instead, we focused on the relatively uncharacterized hypothetical gene *lpg1681*, which encodes a small, 105 amino acid protein with no predicted domains apart from two transmembrane helices. This gene is adjacent in the genome to *lpg1682*, which encodes for a predicted oxidoreductase/dehydrogenase, and *lpg1680*, which encodes for the thiol:disulfide exchange protein DsbD2 ([Figure 5C](#fig5){ref-type="fig"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). Functional studies of DsbD2 (aka DiSulfide Bond reductase D2) have demonstrated that it interacts with thioredoxin to regulate disulfide bond remodeling in the periplasm ([@bib42]; [@bib48]). If *lpg1681* has a redox function related to its neighboring genes, we expected its syntenic locus to be conserved across bacterial strains and species. Consistent with this prediction, we found that the *lpg1680-1682* locus is present and conserved among over 500 sequenced *Lp* strains currently in NCBI databases. Outside *L. pneumophila*, *lpg1681* is mostly restricted to the *Legionella* genus, present in about half of the currently sequenced species ([@bib10]) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). A homolog of *lpg1681* is also found in the draft genome of *Piscirickettsia litoralis*, a gamma proteobacterium and fish pathogen ([@bib85]). In all cases, *lpg1681* resides upstream of *dsbD2*, suggesting a functional link between these proteins ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}) and implicating *lpg1681* in a role in redox homeostasis. We, therefore, viewed *lpg1681* as a promising candidate for a gene involved in HGA susceptibility.

We constructed *lpg1681* overexpression and deletion strains in *Lp* and tested the susceptibility of these strains to HGA. Similar to the spontaneous mutants we recovered, we found that the *∆lpg1681* strain was more resistant to synthetic HGA in rich media ([Figure 5D](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Conversely, overexpression of *lpg1681* increased *Lp* sensitivity, resulting in longer growth delays than wild type at high concentrations of HGA. We therefore conclude that wild type *lpg1681* expression sensitizes *Lp* to inhibition by extracellular HGA. Given its genetic linkage with *DsbD*, our findings further suggest that alteration of disulfide bond regulation in the periplasm might constitute one means to mitigate HGA susceptibility.

*L. pneumophila* susceptibility to HGA is density-dependent {#s2-6}
-----------------------------------------------------------

Our unbiased genetic screen for *Lp* resistance to HGA only revealed mutants that were partially resistant to HGA. These mutants had a smaller growth delay than wild type at a given HGA concentration, but all remained qualitatively susceptible to inhibition. These results suggest that the genetic routes for *Lp* to completely escape from HGA-mediated inhibition are limited. Yet, *Lp* secretes abundant HGA into its local environment, despite the fact that HGA secretion is not required for *Lp* growth or metabolism (as seen by the robust growth of the *hisC2::Tn* mutants, [Figures 2](#fig2){ref-type="fig"} and [4](#fig4){ref-type="fig"}). Thus, our findings do not provide an adequate explanation for the paradox of how *Lp* cells can secrete a toxic compound to which they apparently carry no heritable resistance.

We therefore considered a distinct mechanism by which *Lp* might avoid self-inhibition: *Lp* might produce and secrete HGA only during conditions when it is not susceptible to HGA. To address this possibility, we investigated when and where *Lp* secretes HGA. We tracked HGA secretion across a growth curve of *Lp* in rich media with our previously described conditioned media assay. It has long been known that *Lp* produces abundant HGA-melanin pigment in stationary phase, when the bacteria are undergoing very slow or no growth ([@bib68]; [@bib6]; [@bib87]). By comparing to a synthetic HGA standard curve ([Figure 4---figure supplement 1F](#fig4s1){ref-type="fig"}), we estimate that *Lp* secretes a burst of HGA in stationary phase, producing between 183--266 µM of active HGA within 5 hrs ([Figure 6A](#fig6){ref-type="fig"}). HGA secretion then continues after the population has ceased growing. These quantities of HGA are more than enough to be inhibitory to *Lp* ([Figure 4B](#fig4){ref-type="fig"}).

![HGA susceptibility in *Lp* is linked to cell density, independent of inoculum growth phase.\
(**A**) Timing of HGA secretion in *Lp* in rich media, measured by OD 400 of conditioned media (CM) after allowing for full HGA oxidation (blue boxes, right y-axis). A matched growth curve of *Lp* is presented for comparison (gray circles, left y-axis). Abundant HGA is secreted during stationary phase. Estimates of secreted HGA concentration (blue) are based on a standard curve of synthetic HGA. Error bars show standard deviations. (**B**) Schematic showing how experiments controlled for inoculum density vs. growth phase. To test the impact of cell density, a single culture was diluted to multiple densities at the start of the experiment. To test the impact of growth phase, *Lp* was sampled at multiple stages of growth and diluted to the same CFU/mL at the start of the experiment. (**C**) *Lp* growth in AYE rich media is inhibited by HGA when cells are inoculated at relatively low density (10\^8 CFU/mL), but HGA is ineffective in inhibiting growth when cells are inoculated at high density (10\^9 CFU/mL). Growth phase of *Lp* inoculum has little impact on HGA susceptibility.](elife-46086-fig6){#fig6}

For *Lp* to avoid self-inhibition from HGA, we hypothesized that *Lp* might be resistant to this inhibitor at high density and/or when the cells are in a stationary phase of growth. We therefore investigated if cell density or growth phase impacted HGA susceptibility ([Figure 6B](#fig6){ref-type="fig"}). For *Lp* exposed to HGA in rich media, we found that the growth phase of bacteria used to inoculate the experiment had little impact on HGA susceptibility ([Figure 6C](#fig6){ref-type="fig"}). In contrast, when cells were inoculated at high density (10\^9/mL instead of 10\^8/mL), they were resistant even to high concentrations of HGA ([Figure 6C](#fig6){ref-type="fig"}), suggesting that cell density might be linked to HGA resistance. However, because both cell density and growth phase are changing over time during our assays in rich media, we could not fully separate their contributions to HGA resistance in *Lp*.

We therefore created a new assay to assess HGA susceptibility. We exposed *Lp* bacteria to HGA at different dilutions in nutrient-free PBS, which ensured that the bacteria did not grow or change cell density during the course of the experiment. After 24 hr exposure to 125 µM HGA, we assessed bacterial viability by plating for viable CFUs ([Figure 7A](#fig7){ref-type="fig"}). No measurable darkening of the HGA was detected in this assay, suggesting that the oxidation and de-activation of HGA was considerably slowed in low-nutrient conditions. We found that *Lp* bacteria incubated at high density with HGA (above 10\^8 CFU/mL) were largely protected from inhibition ([Figure 7A](#fig7){ref-type="fig"}). However, at lower density (10\^7 CFU/mL), *Lp* bacteria were extremely sensitive to HGA, with at least a 10\^6-fold reduction in CFUs, to below our limit of detection. This result suggests that, although HGA is bacteriostatic in rich media, it appears to be strongly bacteriocidal in PBS. Nevertheless, as in the rich media assay, the resistance to HGA was dependent on cell density and was not altered by inoculum growth phase ([Figure 7A](#fig7){ref-type="fig"}).

![Density-dependent HGA susceptibility is heightened in low-nutrient media and requires HGA's oxidative intermediates, while high-density resistance is cell-intrinsic.\
(**A**) Viable CFUs following 24 hr incubation of *Lp* with or without 125 µM HGA in PBS. When incubated at high density, bacteria are almost entirely resistant to HGA, while they are highly sensitive at lower density. Dotted line shows the limit of detection. Brackets indicate the fold change in viable CFUs due to HGA exposure. (**B**) Viable CFUs following low-density HGA exposure in aerobic or anaerobic conditions. HGA is not toxic to *Lp* in the absence of oxygen. (**C**) High-density HGA-resistant cells do not inactivate extracellular HGA. Supernatants from *Lp* ±HGA at two densities were collected after 24 hr incubation and applied to new dilute cells for 24 hr. Viable CFUs were counted following supernatant exposure. HGA in all supernatants remained active against low-density *Lp*. (**D**) Model for HGA activity in extracellular environments. *Lp* (orange) colonizes a surface and grows to form a microcolony. Once cells are at high density, they secrete abundant HGA (yellow). Through unknown mechanisms, high-density *Lp* are resistant to HGA's effects (black outline), while low-density *Lp* or other *Legionella* species (blue) are inhibited by HGA and cannot invade the microcolony's niche.](elife-46086-fig7){#fig7}

The dramatic loss in viable CFUs in the PBS assay allowed us to further investigate the mechanism behind low-density susceptibility. Specifically, we asked if this loss in viability was due to HGA or one of its transient oxidative intermediates by exposing cells to HGA in both aerobic and anaerobic conditions. We observed that HGA was not inhibitory to *Lp* in anaerobic conditions ([Figure 7B](#fig7){ref-type="fig"}), suggesting that HGA-mediated toxicity comes from the action of a reactive intermediate molecule generated during HGA oxidation.

We then considered the density-dependent difference in HGA susceptibility, reasoning that quorum sensing would be most likely to control this phenomenon. When we asked if HGA resistance depended on the previously described *Lp* quorum sensing response regulator, *lqsR* ([@bib83]), we found that deleting *lqsR* had no detectable impact on HGA susceptibility or resistance ([Figure 7---figure supplement 1B](#fig7s1){ref-type="fig"}). Therefore, the density-dependent susceptibility of *Lp* to HGA must be independent of the *lqsR* pathway. We next investigated the basis of high-density resistance to HGA by *Lp* bacteria, hypothesizing that high-density cells could alter the activity of extracellular HGA, either through the secretion of inactivating compounds or through bulk, non-specific binding of HGA to bacterial biomass, leading to a reduction in its effective concentration. To test both hypotheses, we recovered the supernatants from high-density and low-density bacteria that had been incubated with or without HGA, and applied these supernatants to fresh, low-density *Lp* to assess HGA activity ([Figure 7C](#fig7){ref-type="fig"}). We found that the supernatants from HGA-exposed *Lp* remained fully inhibitory, even after 24 hr incubation with high-density bacteria. Furthermore, we found that adding heat-killed *Lp* bacterial cells to low-density viable *Lp* bacteria did not enhance the latter's resistance to HGA inhibition ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). Therefore, we conclude that HGA susceptibility appears to be density-dependent and yet cell-intrinsic. Because *Lp* bacteria at high density both secrete and are protected from HGA, this strategy of secreting HGA only when *Lp* cells are conditionally HGA-resistant may allow *Lp* to produce a broadly active inhibitor while restricting the potential for self-harm.

Discussion {#s3}
==========

The HGA-melanin pathway is well-studied and widespread among bacteria and eukaryotes. In this study, we identify HGA's oxidative intermediates as a mediator of inter-*Legionella* inhibition, both between *Legionella* species and even between genetically identical populations of *L. pneumophila*. To our knowledge, this is the first time that HGA has been described to have antimicrobial activity. One reason HGA-mediated inhibition may not have been previously documented is that the active compound(s) are redox-active, unstable molecules with transient activity. Our study finds that synthetic HGA can auto-oxidize over the course of an experiment to form inactive HGA-melanin ([Figure 3](#fig3){ref-type="fig"}, [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}), allowing exposed *Lp* populations to rebound following initial inhibition ([Figure 4B](#fig4){ref-type="fig"}). Intriguingly, although *Lp* populations recover upon HGA oxidation, *Lm* populations do not, suggesting that HGA may cause more harm to *Lm* cells. The quenching of HGA's inhibitory activity occurs especially rapidly in the cysteine-rich microbial media typically used to grow *Legionella* in the lab ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). Conversely, we find that HGA becomes more potent in low-cysteine media or in PBS ([Figure 3F and 7](#fig3){ref-type="fig"}), where oxidation of HGA into HGA-melanin occurs more slowly; such nutrient-poor conditions may better replicate the nutrient-poor (oligotrophic) aquatic environments of *Legionella's* natural habitat ([@bib2]; [@bib8]).

Although dense, stationary-phase cultures of *L. pneumophila* secrete abundant HGA ([Figure 6A](#fig6){ref-type="fig"}, [Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}), we also find that these bacteria do not possess heritable resistance to HGA ([Figure 4B--D](#fig4){ref-type="fig"}) and are highly susceptible to HGA-mediated inhibition at low cell density. However, they exhibit conditional, cell intrinsic resistance to HGA at high cell density ([Figure 6 and 7](#fig6){ref-type="fig"}). This lack of heritable resistance makes HGA-mediated inhibition different from classical antibiotics or toxins, which typically are produced by bacteria that also express resistance genes or antitoxins. HGA inhibition is also distinct from that caused by toxic metabolic by-products in two important ways. First, HGA production is not required for efficient growth or metabolism in *Legionella* species ([Figure 2---figure supplement 1D](#fig2s1){ref-type="fig"}, and see growth of *hisC2*::Tn mutant in [Figure 4A](#fig4){ref-type="fig"}). Second, high-density populations of *L. pneumophila* that produce HGA are themselves protected from HGA inhibition ([Figure 6 and 7](#fig6){ref-type="fig"}). Only neighboring, low-density *Legionella* are strongly inhibited ([Figure 4A and 6D](#fig4){ref-type="fig"}). The strong density-dependence of *Legionella*'s susceptibility to HGA may be another reason that it has been previously undiscovered despite intense study of these bacteria.

HGA-mediated inhibition of *Legionella* is reminiscent of the antimicrobial activities of phenazines, another class of small aromatic molecules including pyocyanin from *Pseudomonas aeruginosa*. Both types of molecules are redox-active ([@bib35]), are produced at high cell density ([@bib35]; [@bib4]), are able to chemically react with thiol groups ([@bib12]; [@bib37]), and result in the production of a colored pigment ([@bib69]). Phenazine inhibitory activity is typically thought to come from redox cycling and the production of reactive oxygen species, including H~2~O~2~ ([@bib35]; [@bib12]). Oddly, HGA-melanin production has previously been implicated both in the production of ([@bib62]) and protection from ([@bib45]; [@bib66]) reactive oxygen species. The catalase experiments presented here have ruled out the production of extracellular H~2~O~2~ as a possible mechanism behind HGA inhibition ([Figure 3---figure supplement 1B--C](#fig3s1){ref-type="fig"}). Instead, based on association of *lpg1681* and *DsbD2* with reduced HGA sensitivity ([Figure 5](#fig5){ref-type="fig"}), the ability of diverse thiols to quench HGA's activity ([Figure 3---figure supplement 1E](#fig3s1){ref-type="fig"}), and precedents from phenazines ([@bib37]), we speculate that HGA's transient, oxidative intermediates may be toxic by forming adducts on cysteine residues or otherwise disrupting disulfide bonding. Alternatively, HGA-mediated inhibition could occur via the production of other reactive oxygen species, including potentially the generation of intracellular superoxide and/or H~2~O~2~ ([@bib34]), which would not be affected by catalase treatment. As both of these mechanisms should be broadly inhibitory to a number of bacterial taxa, it will be interesting to survey HGA susceptibility outside of *Legionella*.

The density-dependence of *Lp*'s resistance to HGA is unusual and worthy of future study. Because high-density cells do not inactivate or bind up extracellular HGA ([Figure 7C](#fig7){ref-type="fig"}) and because heat-killed cells cannot protect live, low-density *Lp* from inhibition ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}), we infer that resistance is cell-intrinsic, resulting from differing physiology and/or gene expression between high- and low-density cells. Two pathways that commonly regulate such defenses include the stringent response pathway, which becomes active under nutrient limitation and stress, and quorum sensing pathways, which become active at high cell density ([@bib3]; [@bib33]; [@bib83]; [@bib16]; [@bib39]). Although our experiments disrupting these pathways suggest that neither pathway contributes to density-dependent susceptibility or resistance ([Figure 7---figure supplement 1B--D](#fig7s1){ref-type="fig"}), we note that quorum sensing in *Legionella* remains understudied, and such pathways vary considerably across bacterial taxa ([@bib39]; [@bib57]). Future work using unbiased approaches to investigate the regulation of HGA susceptibility may be able to uncover additional density-sensing pathways, possibly including an undescribed mode of quorum sensing in *Legionella*. Finally, we note that the density-dependent resistance was observed in well-mixed, liquid cultures in both rich media ([Figure 6C](#fig6){ref-type="fig"}) and in PBS ([Figure 7A](#fig7){ref-type="fig"}). In natural conditions, high-density bacteria may be further protected within anaerobic regions of a biofilm, as HGA was not toxic to *L. pneumophila* in these conditions ([Figure 7B](#fig7){ref-type="fig"}).

*L. pneumophila* is often co-isolated with other *Legionella* species, which likely compete for similar ecological niches ([@bib86]; [@bib67]). HGA-mediated inter-*Legionella* inhibition therefore has a strong potential to impact the success of *Lp* in both natural and man-made environments. Because high-density, established *Lp* bacterial communities are largely resistant to HGA inhibition, these communities might use HGA to protect against low-density, invading *Legionella* competitors with little harm to themselves ([Figure 7D](#fig7){ref-type="fig"}). In this model, motile *Lp* can disperse, colonize a new surface, and grow into a microcolony using the locally available nutrients. In these early stages, no HGA is produced. After the *Lp* population grows up and crosses a certain cell density threshold, the cells become HGA-resistant through a cell-intrinsic mechanism. When this dense population enters stationary phase, it also begins to secrete abundant HGA into the local environment. This secreted HGA has minimal impact on the resistant, producer cells. However, it can inhibit the growth of nearby, low-density *Legionella*, whether the neighboring cells are other *Legionella* species or even genetically-identical *Lp*. Given these dynamics observed in the lab, we speculate that HGA and other such inhibitors may be deployed as a bacterial niche-protective strategy.

Materials and methods {#s4}
=====================

Bacterial strains and growth conditions {#s4-1}
---------------------------------------

The bacterial strains and plasmids used for this study are listed in [Supplementary file 1](#supp1){ref-type="supplementary-material"}. As our wild type *Legionella pneumophila (Lp)* strain, we used KS79, which was derived from JR32 and ultimately from isolate Philadelphia-1 ([@bib18]; [@bib75]; [@bib71]). Compared to JR32, the KS79 strain has a *comR* deletion to enable genetic manipulation ([@bib18]). We used *Legionella micdadei (Lm)* tatlock as our susceptible strain ([@bib30]; [@bib36]). Liquid cultures of *Legionella* were grown shaking in AYE rich liquid media at 37 ˚C ([@bib19]). Unless otherwise indicated, experiments were inoculated with stationary phase *Legionella*, grown from a single colony in AYE for 16--18 hr as described, to a density of 3--4 × 10\^9 CFU/mL. For experiments with log phase *Lp*, an overnight culture was diluted into fresh AYE at 1:8 ratio (to a density of 4--5 × 10\^8 CFU/mL) and allowed to grow to a density of 10\^9 CFU/mL before setting up the experiment.

To manipulate the redox state of AYE, we altered the amount of cysteine added to the media from 0.4 g/L in standard AYE to 0.1, 0.2, and 0.8 g/L. On solid media, *Legionella* were grown either on BCYE agar plates either containing the standard cysteine concentration (0.4 g/L) or 'low cysteine' (0.05 g/L) ([@bib25]; [@bib76]). *E. coli* strains used for cloning were grown in LB media. Where indicated, antibiotics were used at the following concentrations in solid and liquid media, respectively; chloramphenicol (5 µg/mL and 2.5 µg/mL), kanamycin (40 µg/mL) and ampicillin (50 µg/mL and 25 µg/mL). For counter-selection steps while generating deletion strains, 5% sucrose was added to BCYE plates. For agar overlay experiments, we used 0.7% agar dissolved in water, which was kept liquid at 50 ˚C before pouring over low cysteine BCYE plates.

Gene deletions and complementations {#s4-2}
-----------------------------------

Genomic knockouts in *L. pneumophila* were generated as previously described ([@bib87]). Briefly, we used an allelic exchange plasmid (pLAW344) harboring chloramphenicol and ampicillin selection cassettes and the counter-selection marker SacB, which confers sensitivity to sucrose. Into this plasmid, we cloned \~ 1 kb regions upstream and downstream of the gene of interest to enable homologous recombination. Following electroporation and selection on chloramphenicol, we used colony PCR to verify insertion of the plasmid into the chromosome, before counter-selection on sucrose media. From the resulting colonies, we performed PCR and Sanger sequencing to verify clean gene deletion. For complementation, the coding region of a candidate gene was cloned into a plasmid (pMMB207c) following a ptac promoter ([@bib14]). To induce gene expression, strains carrying pMMB207c-derived plasmids were exposed to 1 mM IPTG. All constructs were assembled using Gibson cloning (NEB Catalog \#E2621).

Inhibition assays on agar plates {#s4-3}
--------------------------------

To visualize inhibition between neighboring *Legionella* on solid media, a streak of approximately 5 × 10\^6 CFU of the inhibitory strain of *Lp* was plated across the center of a low cysteine BCYE plate. After 3 days growth at 37 ˚C, dilutions of susceptible *Lp* or *Lm* were plated as 10 µL spots approximately 1 cm and \>2 cm from the central line. Once spots were dry, plates were then incubated for an additional 3 days before scoring for inhibition. This assay was also used to quantify the bactericidal inhibition of *Lm*, with slight modifications. Here, all *Lm* was plated in 20 µL spots at 10\^6 CFU/mL. The time of plating susceptible *Lm* was treated as t = 0. Once spots were dry, plugs were extracted from within the *Lm* spots using the narrow end of a Pasteur pipette. These plugs were transferred into media, vortexed, and plated to quantify CFU. This procedure was repeated after 48 hr at 37 ˚C to compare *Lm* viability and growth within ('near', [Figure 1B--C](#fig1){ref-type="fig"}) or outside ('far') of the zone of inhibition.

For inhibition assays on bacterial lawns, we plated 10 µL drops of either live *Lp* or chemical compounds on top of a lawn of 5 × 10\^7 CFU *Lm* on low cysteine BCYE, and assessed growth of the lawn after 3 days at 37 ˚C. Synthetic HGA (Sigma: \#H0751) was dissolved in water at a concentration of 100 mM and filter sterilized before use. To limit the potential for HGA oxidation prior to use, 100 mM aliquots prepared in water were stored frozen at −20C and discarded after 1--2 weeks. HGA-related compounds, 2-hydroxyphenylacetic acid (Sigma: \#H49804) and 3-hydroxyphenylacetic acid (Sigma: \#H49901), were prepared in the same way. To test the impact of DTT (Sigma: \#43819) and glutathione (oxidized: Sigma \#G4376, reduced: Sigma \#G6529) on HGA-mediated inhibition, filter-sterilized solutions dissolved in water were mixed in equimolar ratios with HGA, and incubated shaking at room temperature for 1 hr before spotting onto bacterial lawns. HGA-melanin pigment was prepared from *Lp* conditioned media as previously described ([@bib89]) from KS79, the unpigmented *hisC2*::Tn mutant, and the hyperpigmented ∆*hmgA* mutant. Briefly, conditioned media was collected and sterile filtered from 100 mL cultures of *Lp* in AYE media grown shaking at 37 ˚C for 3 days. The conditioned media was acidified to a pH of 1.5 and transferred to 4 ˚C for 2 hr to precipitate. Precipitated pigment was collected by centrifugation at 4000 x g for 15 min and then washed with 10 mM HCl. Pelleted pigment was then returned to neutral pH and resuspended in PBS at 10X before testing.

Transposon mutagenesis screen {#s4-4}
-----------------------------

For random transposon insertion mutagenesis, we used a Mariner transposon from the pTO100 plasmid ([@bib64]). We electroporated this plasmid into the KS79 strain and allowed cells to recover at 37 ˚C for 5 hr. To select for cells with integrated transposons, cultures were plated on BCYE/Kan/sucrose plates and incubated at 37 ˚C for 3 days before screening individual mutant colonies.

To identify transposon mutants with defects in *Lm* inhibition, we transferred each *Lp* mutant onto a low cysteine plate with a lawn of 5 × 10\^7 CFU *Lm* and visually screened for those with either small zones of inhibition or no zone of inhibition. This transfer of *Lp* mutants was achieved either by replica plating using sterile Whatman paper (Whatman: \#1001150) or by manual transfer with a sterile toothpick. Plates were then incubated at 37 ˚C for 3 days and scored. All putative mutants underwent clonal re-isolation, were diluted to OD 600 of 0.1, and spotted on fresh *Lm* lawns to retest their phenotypes. To map the sites of transposon integration, we used arbitrary PCR as described in [@bib13], with primers redesigned to work with the pTO100 transposon ([Supplementary file 1](#supp1){ref-type="supplementary-material"}). Briefly, this protocol involved two PCR steps to amplify the DNA flanking the transposon. The first step used low annealing temperatures to allow the arb1 randomized primer to bind many sites in the flanking DNA while the pTO100_F or pTO100_R primer annealed within the transposon, generating multiple products that overlapped the flanking DNA. These products were amplified in the second step PCR using the arb2 and pTO100_Rd2 primers, and we used the pTO100_Rd2 primer for Sanger sequencing. PCR programs and conditions were as in [@bib13].

HGA inhibition assays in AYE rich media {#s4-5}
---------------------------------------

For rich media assays (e.g. [Figures 3C--F](#fig3){ref-type="fig"}, [4B and D](#fig4){ref-type="fig"}), overnight cultures of *Legionella* were diluted to 10\^8 CFU/mL in AYE, mixed with synthetic HGA (at 0, 62.5, 125, 250, or 500 µM final) or with isolated pigment in 96 well plates, and grown shaking at 425 cpm at 37 ˚C. The cytation three imaging reader (BioTek CYT3MV) was used to monitor growth by OD 600 measurements. Because oxidized pigment from synthetic HGA is detected at OD 600 as well, each experiment included bacteria-free control wells containing media and each concentration of HGA. To correct OD 600 readings for pigment development, at each time point we subtracted the control well reading from bacterial wells that received the same concentration of synthetic HGA.

For experiments with HGA 'pre-oxidation' ([Figure 3D](#fig3){ref-type="fig"}), we diluted HGA in AYE media and incubated this solution shaking at 37 ˚C for 24 hr in the plate reader before adding *Lm* bacteria. Complete oxidation of HGA during the 24 hr was monitored using OD 400 to track the accumulation of HGA-melanin pigment ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). To test if extracellular catalase could protect from HGA inhibition ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), we incubated *Lm* at 10\^7 CFU/mL with or without 125 µM HGA and either 0, 1, 10, or 100 U/mL of bovine catalase (Sigma \#C30). As a control to ensure that the catalase was active, we incubated *Lp* as above with catalase and 2 mM H~2~O~2~ (Sigma \#88597).

In *Lp*, HGA inhibition in AYE rich media resulted in a growth delay, similar to an extended lag phase ([Figure 4B](#fig4){ref-type="fig"}). To determine if this delay was due to genetic adaptation, we sampled *Lp* after 70 hr growth with 250 µM HGA or without HGA ([Figure 4C--D](#fig4){ref-type="fig"}). These bacteria were washed once and resuspended in fresh AYE, before being diluted back to 10\^8 CFU/mL and then exposed to fresh, synthetic HGA as above. To assess the correlation between HGA oxidation and the length of the *Lp* growth delay ([Figure 4E](#fig4){ref-type="fig"}), we pooled data from eight experiments on different days that measured wild type *Lp* (KS79) exposed to a range of HGA concentrations in AYE. We considered the 'Time to full HGA oxidation' as the length of time required for a given concentration of HGA to stop forming additional HGA-melanin, measured as the time until OD 400 readings increased by less than or equal to 0.001 units per hour. The 'Time to mid-log' was measured as the time when *Lp* exposed to that concentration of HGA had grown to an OD 600 of 0.1.

To compare sensitivity to HGA among *Lp* strains, we calculated the lag phase from the growth curve of each well using the GrowthRates program ([@bib32]). We excluded a small number of samples where the growth curve was not well fit (R \< 0.99), and then for each strain used the difference in lag time between the samples with and without HGA to calculate the growth delay due to HGA ([Figure 5D](#fig5){ref-type="fig"}).

HGA inhibition assays in PBS {#s4-6}
----------------------------

While we were able to manipulate inoculum growth phase and cell density in the AYE assays, during these experiments the bacteria altered their density and growth phase as they grew in rich media. To separate the impacts of cell density and growth phase on HGA susceptibility, we used a complementary assay in which we evaluated *Legionella* viability when exposed to HGA in nutrient-free PBS at different cell densities. This design ensured that the bacteria maintained a constant cell density throughout the course of the experiment. Stationary phase cultures were washed 1--2 times and re-suspended in PBS. We diluted these bacteria to estimated starting concentrations of 10\^9, 10\^8, and 10\^7 CFU/mL and plated for CFU at t = 0. We distributed the remaining bacteria into 96 well plates with or without 125 µM HGA. Plates were incubated shaking in a plate reader at 425 cpm at 37 ˚C for 24 hr before plating to quantify CFUs on BCYE plates. CFUs were counted after 3--4 days growth at 37 ˚C. To assess HGA toxicity in aerobic vs. anaerobic conditions, *Lp* stationary phase bacteria were prepared as above and diluted to 10\^8 CFU/mL in PBS ± 125 µM HGA in 500 uL volumes in Celltreat bio-reaction tubes (\# 229472). Aerobic samples were incubated shaking in air at 37 ˚C for 24 hr, while anaerobic samples were incubated static at 37 ˚C in an anaerobic chamber (Coy lab products, \#032714) filled with 5% hydrogen, 10% CO2, and 85% N2. Samples were plated to quantify CFUs as above.

To determine if high density bacteria were protected via mass action effects that diluted out the amount of HGA per cell through binding of bulk material, we asked if the addition of dense, heat-killed bacteria could protect low-density *Lp* from HGA ([Figure 7---figure supplement 1A](#fig7s1){ref-type="fig"}). To prepare high-density heat-killed bacteria, an overnight culture of *Lp* was washed once in PBS, resuspended to 2 × 10\^9 CFU/mL, and incubated at 100--110˚C for 60 min. After heating, this sample was diluted 1:2 and mixed with 10\^7 CFU/mL live *Lp* in PBS ± 125 µM HGA to assess protection. As a control, 10\^9 and 10\^7 CFU/mL live *Lp* with or without HGA were tested simultaneously. Cells were incubated and plated as above to assess viability. To determine if high density bacteria were protected via HGA degradation, we tested if the supernatants from HGA-exposed, high-density bacteria retained the potency to inhibit low-density bacteria ([Figure 7C](#fig7){ref-type="fig"}). To generate supernatants, we set up 2 mL samples containing 10\^8 or 10\^7 CFU/mL of *Lp* in PBS ± 125 µM HGA and incubated them shaking at 37 ˚C for 20 hr. After plating aliquots for viable CFU, we pelleted the remaining bacteria and sterile filtered 1 mL of each supernatant through a 0.2 µm filter. Each supernatant was tested in triplicate, incubated with fresh *Lp* at 10\^7 CFU/mL in a 96 well plate as above for 24 hr before plating for CFU. As a control, 10\^7 CFU/mL live *Lp* were incubated in PBS alone.

Quantification of HGA's ability to react with cysteine {#s4-7}
------------------------------------------------------

HGA is known to be a redox-active molecule, with a redox potential of +0.636V ([@bib23]). As this measurement can be altered by pH and temperature, we assessed the ability for HGA to oxidize cysteine in our experimental conditions using Ellman's reagent (also known as 5,5'-dithiobis-(2-nitrobenzoic acid), DTNB, Invitrogen \#D8451). Ellman's reagent reacts in the presence of reduced thiol groups on L-cysteine to form a yellow color, which can be read as 412 nm absorbance. When thiol groups are oxidized, the Ellman's reagent is colorless. We used the ability for HGA to decrease the amount of reduced cysteine as a proxy for its oxidizing ability. Stock solutions of both 100 mM HGA and 1.5 mM L-cysteine (Sigma \#C6852) were prepared fresh in PBS at the start of the experiment. Different concentrations of HGA (from 125 µM to 8 mM) were incubated in triplicate, shaking at 25°C with 1.5 mM cysteine in PBS for 16 hr. These conditions were compared to a standard curve of cysteine from 0 to 2 mM, which were incubated in parallel with the experimental samples to account for cysteine oxidation over time. To quantify the remaining free thiol groups, 180 uL of 0.08 mg/mL Ellman's reagent was mixed with 17.65 uL of each experimental or standard sample in a 96 well plate, incubated for 3 hr at 25°C, and read for 412 nm absorbance. The 'decrease in reduced cysteine' was calculated as the difference between the initial and final measured cysteine concentrations, based on the standard curve conversion.

Estimation of amount of HGA secreted by *Lp* {#s4-8}
--------------------------------------------

HGA-melanin is a black-brown pigment that is easily detected at OD 400. We took advantage of this coloration to estimate the amount of HGA that had been secreted by *Lp* by comparing the color of conditioned media to a standard curve of oxidized synthetic HGA. To isolate conditioned media from pigment mutant strains, cultures of KS79, ∆*hmgA*, and hisC2::Tn were inoculated from fresh colonies from a BCYE plate into 5 mL AYE and were grown shaking at 37 ˚C for 48 hr. We then collected conditioned media by pelleting the bacteria and passing the supernatant through a 0.2 µm filter. To harvest conditioned media for a time course, cultures of *Lp* were inoculated into 5 ml AYE and grown shaking at 37 ˚C. After 15, 20, 24, 39, 44, and 48 hr, we measured the OD 600 of the culture and collected conditioned media. To create a standard curve, we diluted synthetic HGA into AYE at the following concentrations: 62.5 µM, 125 µM, 250 µM, 500 µM, and 1 mM. The conditioned media and standard curve samples were incubated in a 96 well plate in a plate reader shaking at 37 ˚C for 24 hr to allow the HGA to oxidize. We used OD 400 data from the 24 hr time point to generate a standard curve for each HGA concentration and calculated a line of best fit using linear regression. This equation was used to estimate the amount of secreted HGA that corresponded to the OD 400 of each conditioned media sample. ([Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). In these results, we saw that the pool of HGA + HGA melanin increased by 266 µM within 5 hr. Based on the HGA-melanin production kinetics we measured in AYE ([Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}) where 250 µM HGA oxidized \~ 31% in the first 5 hr, we calculated the likely range of active HGA concentrations. If all 266 µM HGA were secreted instantaneously at the beginning of the 5 hr window, by the end of that window 266 x (1--0.31)=183 µM of active HGA would remain. Therefore, we estimate that 183--266 µM of active HGA was produced during the 5 hr window.

HGA-resistant mutants {#s4-9}
---------------------

Because the inhibitory activity of HGA is quenched through interactions with cysteine in rich media (e.g. [Figure 3F](#fig3){ref-type="fig"}), it was not possible to select for HGA-resistant mutants by mixing HGA into BCYE agar. Instead, to reduce the potential for HGA to react with media components while allowing sufficient access to nutrients for mutant cells to grow, we selected for HGA-resistant mutants by mixing 4 × 10\^7 CFU *Legionella* with 1 mM HGA in 4 mL of 0.7% molten agar and pouring this solution as an overlay on a low cysteine BCYE plate. Plates were incubated at 37 ˚C for 6 days, before candidate resistant colonies were picked and clonally isolated. The HGA resistance and growth of each isolate was re-tested on overlays with or without 1 mM HGA on both regular and low cysteine BCYE.

Twenty-nine isolates were more resistant to HGA than wild type *Lp* upon retesting. We sequenced and analyzed genomic DNA from these isolates and a matched wild type strain as follows. DNA was prepared from each strain using a Purelink genomic DNA mini kit (Invitrogen, \#K1820). DNA concentrations were quantified using Qubit and normalized to 0.5 ng/uL. Barcoded libraries were prepared using tagmentation according to [@bib5][@bib5], analyzed with QuantIT DNA quantification, pooled, and sequenced with 50 bp paired-end reads on an Illumina HiSeq 2500 machine. Reads were trimmed for quality and to remove Nextera indices with Trimmomatic ([@bib9]) and mapped to the Philadelphia-1 genome ([@bib15]) using Bowtie2 with default parameters ([@bib49]). Coverage plots were generated for each strain using bamcoverage ([@bib70]) and manually examined for evidence of large genomic deletions and amplifications. None were observed, apart from a prophage that was present in the reference genome but missing from all sequenced strains, including our wild type KS79 strain. Variants were detected for each mutant using Naive Variant Caller ([@bib7]). Those variants that were detected in mutant strains but not the wild type strain were considered as putative causative mutations. For each of these mutations, we inspected the mapped reads and excluded faulty variant calls that either were adjacent to coverage gaps or that did not appear to be fixed in the clonal mutant and/or wild type sequences, likely due to errors in read mapping. After this manual filtering, 1--3 well-supported mutations remained for each mutant genome. Nine of the mutants were isolated on a different day from the other mutants; in addition to various unshared mutations, these nine strains each carried exactly the same missense mutation in *rplX*, which we disregarded as a background mutation that likely arose before selection. Following this exclusion, each mutant carried only a single well-supported mutation in a coding region. Most often this coding mutation was the only mutation we detected, although one mutant carried two additional intergenic point mutations. The coding mutations were point mutations or small deletions that resulted in non-synonymous changes, frame shifts, or gene extensions. Across different mutants, the mutations we uncovered were repeatedly found in the same, few loci ([Table 1](#table1){ref-type="table"}).

Evolution of *lpg1681* {#s4-10}
----------------------

The genes in the HGA-melanin synthesis pathway are highly conserved in diverse bacteria and across the *Legionella* genus, with all genes present in all 41 currently sequenced *Legionella spp.* genomes ([@bib10]). In contrast, we were able to identify *lpg1681* in only 30 *Legionella spp.* genomes, as well as a single draft genome outside the *Legionella* genus-- *Piscirickettsia litoralis*, an intracellular fish pathogen ([@bib85]). Across the *lpg1681*-containing genomes, there is evidence for extensive recombination of the flanking loci, yet *lpg1681* is always found upstream of *dsbD2*. We identified most of these homologs of *lpg1681* using a jackhmmr search ([@bib27]), followed by cross-referencing the homologs with the *Legionella* orthology groups defined by [@bib10]. From this starting set, additional *lpg1681* orthologs were identified in unannotated, intergenic regions by searching for \> 200 bp open reading frames upstream of *dsbD* orthologs, and confirming the homology of these regions using MAFFT alignments ([@bib44]). Through this method, we located *lpg1681* in all currently sequenced *Legionella* genomes that contain an annotated *dsbD2* gene, with the exception of *L. shakespearei.* We categorized the *lpg1681*-containing loci into those with similar synteny, based on the orthology group annotations in [@bib10]. We colored and provided names for the neighboring genes in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"} if they had a homolog in the *L. pneumophila* Philadelphia-1 genome that was not annotated as a hypothetical gene. To assess the conservation of the *lpg1680-lpg1682* among *L. pneumophila* strains, we used blastn in the NCBI nr and wgs databases with the full *lpg1680-lpg1682* genomic DNA sequence as a query. We found that the full region was conserved with few mutations across 501 currently sequenced *L. pneumophila* strains.
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\[Editors' note: a previous version of this study was rejected after peer review, but the authors submitted for reconsideration. The first decision letter after peer review is shown below.\]

Thank you for submitting your work entitled \"*L. pneumophila* deploys a self-active inhibitor for inter-*Legionella* competition\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and a Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Michele Swanson (Reviewer \#2).

Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in *eLife* at this time.

We note that there is much to like about your manuscript. The initial description of the HGA-inhibitory activity is interesting, and the genetic experiments are well done. However, it falls short on a few fronts of the quality we seek for an *eLife* manuscript, so we are returning this version of the manuscript yet providing strong encouragement to resubmit pending revision and additional experimentation. Attention should be focused on the following things:

The design, presentation and interpretation of the cell density experiments lack the context of the well-described cellular differentiation coordinated by the stringent response for Legionella. Suggestions for how to address this are found below.

More direct experimentation to characterize the redox properties of HGA and links to ROS pathways would strengthen the mechanistic claims. Suggestions for how to address this are found below.

Ecological claims are provocative, yet overstated. Please tighten the discussion, condensing the \"social goods\" part yet providing more detail on evidence of interspecies Legionella competition in the environment. Use of \"for inter-Legionella competition\" in the title is not appropriate.

Claims of novelty for HGA having dual effects on their producers compared to phenazines are incorrect, and the discussion should be revised accordingly. Several years ago it was demonstrated that phenazines trigger lysis of the producing *Pseudomonas* population via ROS-linked effects (see papers by Das and Manefield), and a recent study describes when and how phenazines are toxic vs. beneficial to their produces (see Meirelles and Newman, 2018).

*Reviewer \#1:*

While this manuscript takes an impressive genetics approach to an interesting observation, at the end of the day, the key biological insights here aren\'t clear. Similar things have been reported for phenazines: they can be both beneficial under some circumstances, and harmful under others, including harmful to the producing cells (they are \"self-active\", see work on eDNA release, for example). The more interesting question is why is HGA toxic to the producers? That, unfortunately, isn\'t clarified here, and without deeper insight into this aspect, this paper falls short of the *eLife* bar.

Essential revisions:

\- An oxidative stress mechanism is asserted but not rigorously tested. What is the redox potential of HGA? What factors in the cell respond to it? The screen for resistance found a number of general-growth defects, but unfortunately, they don\'t shed much light on the mechanism.

\- Insufficient physiological description of state of cultures used in experiments (cell density/growth stage of inoculum?). Energy state? Please state and measure, where possible.

\- Ecological relevance seems more asserted than supported by data. Where has HGA been shown to be important?

\- Discussion section is overly speculative and unfocused.

*Reviewer \#2:*

Levin and colleagues identified a new activity of a pigment produced by *Legionella* -- a redox-sensitive inhibition of growth. By applying a logical series of genetic and biological assays, they also identified a previously uncharacterized locus that modulates bacterial sensitivity to the HGA pigment. The authors discuss their results within a provocative ecological framework, proposing that, by secreting the pigment in stationary phase, *L. pneumophila* restricts encroachment by competitor *Legionella*.

In general, the experiments are logical, quantitative, and well controlled, and the primary conclusions are supported by data provided. The value of the manuscript is to advance the scant literature on mechanisms of ecological fitness of *L. pneumophila* in aquatic environments, the source of transmission to humans. Ambiguity concerning growth phase vs cell density complicates independent interpretation and replication of the results, a weakness that can be corrected by editing and/or comparing directly log and stationary phase WT cells in their HGA-sensitivity assay.

1\) Cell density vs growth phase: Abstract, Results section, Discussion section; Figure 4, Figure 5, Figure 4---figure supplement 1 and elsewhere. *L. pneumophila* induce expression of multiple virulence and resilience traits upon entry into stationary phase, whereas exponential phase cells are more susceptible to killing by macrophages and a variety of environmental stresses (e.g. Molofsky and Swanson, 2004; Olivia et al., 2018). Accordingly, in experiments testing sensitivity of *Legionella* to HGA, clarify in Materials and methods section and relevant figure legends the growth phase of the cells that were challenged with HGA. Currently, the references to \"regulatory state\" (Discussion section) are vague and not tested directly here.

2\) HGA induces transient \"growth delay\", Figure 4, Figure 5, Figure 4---figure supplement 1, Figure 5---figure supplement 2, and Results section \"improvement in growth\": Without knowing the growth phase of inocula used throughout this study, it is difficult to interpret the apparent prolonged lag phase of HGA-treated cells: Does HGA kill a large subset of the treated population, or instead delay entrance into the cell cycle for the entire population? If the latter, do you speculate that HGA loses activity or instead that the bacteria adapt to overcome the HGA block to replication?

3\) Cell density protection, Figure 4D, Figure 4---figure supplement 1, and Results section: Do cells need to be metabolically active to confer protection from HGA, or is this a biochemical effect of distributing the oxidative damage across more substrate -- more surface area of stationary phase L. pneumophila cells? For example, do UV-inactivated bacteria protect a minority population of viable stationary phase cells? Related to \#1, at high densities, are log phase cells also protected from HGA treatment?

4\) Title and Discussion section, \"observed specificity\": Whether HGA also inhibits non-*Legionella* bacteria is predicted from the Stewart et al., 2011 study of surfactant and implied here but is not tested directly. Also, this paragraph focuses on pigments, but cites Stewart et al., 2011 that only analyzes surfactant.

5\) Translation mutants alter HGA susceptibility, Results section: Nam et al., 2016 reported that disruption of elongation factor P function induces the stringent response of *Salmonella*. Since the stringent response triggers entry of replicating *L. pneumophila* into stationary phase and the more resilient \"transmissive\" cell type (e.g. Molofsky and Swanson, 2004; Olivia et al., 2018), the authors may wish to comment on whether activation of the stringent response might account for the isolation of a large number of translation mutants in the screen for enhanced resistance to HGA.

*Reviewer \#3:*

Levin et al. identify an important mechanism that *Legionella pneumophila* may employ to successfully compete in complex multispecies communities. Specifically, demonstrate that interbacterial competition between closely related *Legionella* species is mediated in part by the secretion of the inhibitory molecule homogentisic acid by *L. pneumophila*. This work is important as it reveals a novel mechanism this pathogen may use to thrive in the environment. They identify HGA as the inhibitory molecule using a random transposon mutagenesis approach and further characterize mutations that increase resistance to HGA in the producing strain. Cysteine is shown to protect cells from the toxic effects of HGA and the oxidized form of the molecule (HGA-melanin) is non-toxic, suggesting that redox activity of HGA is important for the mechanism of inhibition. The work is well done, and the manuscript is well written.

\[Editors' note: what now follows is the decision letter after the authors submitted for further consideration.\]

Thank you for resubmitting your work entitled \"Density-dependent resistance protects *Legionella pneumophila* from its own antimicrobial metabolite, HGA\" for further consideration at *eLife*. Your revised article has been favorably evaluated by Gisela Storz (Senior Editor), a Reviewing Editor, and three reviewers.

Overall, you have done an outstanding job in responding to the first set of reviews, and this manuscript is on-track for acceptance in *eLife*. However, the reviewers made a few suggestions that are constructive, which you will likely want to incorporate into your final manuscript prior to publication. The goal here is to help you polish your work one last time, but not to add onerous new experiments. No additional new experimentation is required, but should you want to try one quick experiment independently suggested by reviewer 1 and reviewer 3, please go for it.

We look forward to receiving your final revised manuscript and processing it for publication shortly!

*Reviewer \#1:*

This manuscript has improved significantly and the authors are to be commended for doing a great job in response to the previous set of reviews. The new experiments aimed at bolstering the interpretation of the HGA toxicity mechanism have elevated the work, and the comparison with phenazines in the discussion is clarifying. The manuscript is much better focused and thoughtfully discussed, and makes an interesting new contribution to the literature on secondary metabolism, an important and understudied aspect of bacterial physiology. Why much remains to be learned about the mechanism(s) underpinning the phenotypes reported here, the authors have ruled out the usual suspects and have revealed an intriguing phenomenon that will inspire future work to fill in the molecular details and test the potential ecological importance of the finding, both worthy goals.

*Reviewer \#2:*

The authors have thoughtfully and rigorously addressed each of the gaps noted in their first submission. This significantly expanded and revised manuscript is impressive in its scope, incorporating a logical series of microbiological, genetic, bioinformatic, and biochemical approaches to identify a new activity for a pigment that has long been known to be produced by the environmental opportunistic pathogen *Legionella pneumophila*. Using a clever series of quantitative assays, they convincingly demonstrate that in the stationary phase, *L. pneumophila* secretes HGA which inhibits replication of other legionellae that are present at low density, whether in log or stationary phase (Figure 6F). Based on several systematic tests of multiple potential mechanisms, they demonstrate that both regulation and activity of the HGA inhibitor have novel features that warrant continued investigation. The authors discuss their data within a provocative ecological framework that will guide future research in the field.

Altogether, the study marks a significant advance for the *Legionella* field, where mechanistic knowledge of this pathogen\'s strategies for persistence in the environment remains scant, despite *L. pneumophila* now being the leading cause of water-associated infectious disease in the USA. The clearly written manuscript is also highly accessible for the broad audience that will be interested in this new environmental microbiology, thanks to multiple schematic diagrams that beautifully illustrate the experimental design (eg Figure 2A, Figure 3A, Figure 5A, Figure 6B, D, E).

*Reviewer \#3:*

Levin et al., have modified their previous manuscript in response to earlier reviews. The focus is narrowed to highlight the role of HGA in inhibiting *Legionella* spp. and that resistance to this inhibition is density dependent the producing species, *Lp*. This inhibition is shown to be independent of secreted surfactants, disproving a hypothesis previously set forth in the field. The secreted inhibitory factor is identified as HGA using a clever genetic screen for transposon mutants, and HGA is later shown to be inhibitory at biologically relevant concentrations. They show that this inhibitory activity is due to HGA and that catalase was not protective suggesting that inhibition is not due to the production of H~2~O~2~ through side reactions. They further show evidence that HGA inhibition is bacteriostatic rather than bacteriocidal in *Lp* and perform a forward genetic selection to identify genes that allow for growth in the presence of HGA. Unsurprisingly, they identify many genes that likely have global effects, and focus on one gene that was mutated in a subset of the population. The authors speculate that periplasmic disulfide bond formation may be important to mediate the cellular response to HGA, but no direct evidence is given. This resistance response may be density, but not growth phase, dependent and cell-intrinsic.

Several new experiments strengthen this version of the manuscript and address many questions raised previously. While the authors are unable to identify a mechanism by which HGA inhibits cells or LP gains resistance, many \"obvious\" candidates are tested and determined to not play a role and it is likely that resistance mechanisms will have global cellular effects that are difficult to tease apart. This is an interesting first observation of the phenomenon and should be of interest to a broad group of scientists.

10.7554/eLife.46086.024

Author response

\[Editors' note: the author responses to the first round of peer review follow.\]

> Our decision has been reached after consultation between the reviewers. Based on these discussions and the individual reviews below, we regret to inform you that your work will not be considered further for publication in eLife at this time.
>
> We note that there is much to like about your manuscript. The initial description of the HGA-inhibitory activity is interesting and the genetic experiments are well done. However, it falls short on a few fronts of the quality we seek for an eLife manuscript, so we are returning this version of the manuscript yet providing strong encouragement to resubmit pending revision and additional experimentation. Attention should be focused on the following things:
>
> The design, presentation and interpretation of the cell density experiments lack the context of the well-described cellular differentiation coordinated by the stringent response for Legionella. Suggestions for how to address this are found below.
>
> More direct experimentation to characterize the redox properties of HGA and links to ROS pathways would strengthen the mechanistic claims. Suggestions for how to address this are found below.
>
> Ecological claims are provocative, yet overstated. Please tighten the discussion, condensing the \"social goods\" part yet providing more detail on evidence of interspecies Legionella competition in the environment. Use of \"for inter-Legionella competition\" in the title is not appropriate.
>
> Claims of novelty for HGA having dual effects on their producers compared to phenazines are incorrect, and the discussion should be revised accordingly. Several years ago it was demonstrated that phenazines trigger lysis of the producing Pseudomonas population via ROS-linked effects (see papers by Das and Manefield), and a recent study describes when and how phenazines are toxic vs. beneficial to their produces (see Meirelles and Newman, Mol. Micro.).

There were four chief criticisms and suggestions by the reviewers. They felt that our study was not as complete as desired. They provided guidance for refocusing our revision with several additional experiments, which we have now performed over the past five months. These additional experiments and their follow-ups have now resulted in an additional two and a half main figures (and some associated supplementary figures) in our revision. We have also extensively revised our manuscript to focus on our findings. We believe that our revisions and new experiments have now addressed the majority, if not all, of the reviewers' comments. In light of the editor's encouragement, we are therefore resubmitting our manuscript for reconsideration at *eLife*. To aid your appraisal, we highlight the main changes in our revision below. A point-by-point response to the reviewer comments follows after.

1\) We have performed additional experiments to show that HGA inhibition of *L. pneumophila (Lp)* is bacteriostatic in rich media. The *Lp* population rebounds in our experiments in rich media reflect delayed growth, which occurs after HGA has oxidized and is no longer inhibitory. Specifically, we are able to rule out an alternative hypothesis of genetic adaptation i.e., that the inhibition curves reflected killing followed by outgrowth of resistant mutants. This behavior differs from nutrient-poor media like PBS, where HGA appears to be bacteriocidal.

2\) We perform additional experiments in both rich media and PBS to demonstrate that *Lp* resistance to HGA is associated with cell density and not growth phase. We note that we had already ruled out the role of the known quorum sensing pathway in this resistance, concluding that this resistance must therefore constitute a distinct density dependent phenomenon.

3\) We perform additional experiments to show that HGA resistance at high density appears to be cell-intrinsic, and not a result of HGA inactivation or cell mass mediated mitigation of HGA inhibition. We show that supernatants from high-density, HGA exposed cells retain activity against low-density cells, demonstrating that extracellular HGA has not been inactivated or otherwise lost activity in the high-density condition. Moreover, we show that low-density live cells, spiked into high-density heat-killed cells, are not protected from HGA. Therefore, protection at high-density is not due to generic HGA binding to excess cellular material.

4\) Following up on our findings of elongation factor P mutations that increase resistance to HGA, and reviewer suggestions, we now evaluate and rule out the role of *Legionella's* stringent response in mediating HGA resistance. We find that mutations to the stringent response pathway have no impact on either *L. pneumophila* susceptibility to HGA or on bacterial resistance at high density.

5\) We have added significant experimentation beyond what was suggested by the reviewers to test the redox hypothesis for HGA inhibition. We measure the redox properties of HGA. We also test and rule out the hypothesis that HGA inhibits by generating extracellular H~2~O~2~ by testing if catalase can rescue HGA inhibition; it cannot.

6\) We have minimized our previous speculation about the ecological context of this HGA inhibition and resistance, while clarifying our comparisons in the text between HGA and phenazines. This is also reflected in our rephrasing of the title as suggested by the editor to focus more on our findings and speculate less about their implications.

> Reviewer \#1:
>
> While this manuscript takes an impressive genetics approach to an interesting observation, at the end of the day, the key biological insights here aren\'t clear. Similar things have been reported for phenazines: they can be both beneficial under some circumstances, and harmful under others, including harmful to the producing cells (they are \"self-active\", see work on eDNA release, for example). The more interesting question is why is HGA toxic to the producers? That, unfortunately, isn\'t clarified here, and without deeper insight into this aspect, this paper falls short of the eLife bar.

We acknowledge that the relevant points were not clearly explained in our original manuscript, and attempt to do better in our revision.

The interesting and unexpected feature is that HGA has vastly different impacts on adjacent, genetically-identical bacteria depending on their cell density. Specifically, high-density cells produce abundant HGA, which is not harmful to the producing cells but is harmful to their low-density neighbors in the same environment. This makes the phenomenon of HGA inhibition different from the production of antimicrobials such as antibiotics or toxins, because there is not constitutive resistance via a resistance gene or antitoxin. At the same time, HGA's mode of action is also distinct from the release of generically toxic metabolites that would harm both producing and neighboring cells (as is true for phenazines that trigger eDNA release), because *Legionella* exhibit conditional, cell intrinsic, high-density resistance (see new Figure 6C-E). This phenomenon is different from a shift in the cost-benefit balance of phenazines across environments, which we believe the reviewer is referring to here. Nevertheless, there remain parallels between the action of HGA and phenazines, which we highlight in our new Discussion section.

As mentioned in points 2, 3, and 4 above, we now present additional data in our revision investigating the mode of HGA inhibition and resistance. We show that HGA's activity vs. *L. pneumophila* is bacteriostatic in rich media, with population rebounds occurring after HGA becomes sufficiently oxidized and inactive (Figure 3). We also demonstrate that the density-dependence of resistance is separate from growth phase and is cell-intrinsic (Figure 6).

In our new experiments investigating the basis of resistance, we have ruled out several potential mechanisms including extracellular inactivation of HGA (Figure 6E), quorum sensing via *lqsR* (Figure 7---figure supplement 1B), stringent response pathway signaling via ppGpp (Figure 7---figure supplement 1C-D), and mass action effects through excess cellular material (Figure 7---figure supplement 1A). We have also ruled out the possibility that HGA acts by generating extracellular H~2~O~2~ (Figure 3---figure supplement 1C), a mechanism that is typical for phenazines. Through these experiments, we have tested the most probable mechanisms of action and resistance for HGA. We believe that the fact that HGA does not behave according to many of these expectations (notably, expectations that were based primarily on precedents from phenazines) makes this activity even more interesting than we initially appreciated.

> Essential revisions:
>
> \- An oxidative stress mechanism is asserted but not rigorously tested. What is the redox potential of HGA? What factors in the cell respond to it? The screen for resistance found a number of general-growth defects, but unfortunately, they don\'t shed much light on the mechanism.

The reviewer raises a fair point. The redox potential of HGA has been previously measured to be +0.636V (Eslami et al., 2013); we have now added this citation to our revision. Because these values can be altered by experimental conditions such as pH, we have also now quantified the ability of HGA to reduce cysteine in our experimental conditions (Figure 3---figure supplement 1D).

Our data certainly demonstrate that only certain redox states of HGA are active (Figure 3), but they did not necessarily show that inhibition proceeds via oxidative stress. Indeed, our new finding that catalase does not protect from HGA (Figure 3---figure supplement 1B-C) shows that production of extracellular H~2~O~2~ is not involved. We have now been more precise with our wording to indicate this distinction.

In terms of our genetic screen for resistance to HGA, we do discuss two classes in detail in our revision. The first, most abundant class is that of genes involved in elongation factor P biology in translation. On the recommendation of reviewer 2, we investigate the stringent response pathway (because of its link to elongation factor P) but find it does not play a detectable role in HGA resistance. We also investigate *lpg1681*, a previously uncharacterized gene,and suggest that partial HGA resistance can result from altered regulation of periplasmic disulfide bonding. We note that all mutations we recovered in this second screen provided only partial resistance to HGA inactivation. Yet, we unexpectedly observe nearly complete phenotypic resistance to HGA when *Lp* cells are at high density. This phenotypic resistance is density dependent and cell intrinsic, but not dependent on inoculum growth phase or on activation of the stringent response or known quorum-sensing pathway. We believe it is these observations, along with our elucidation of the *Lp* population rebound in rich media, which elevate the impact of our manuscript.

> \- Insufficient physiological description of state of cultures used in experiments (cell density/growth stage of inoculum?). Energy state? Please state and measure, where possible.

We apologize for the scant description in our earlier version. We have now added the information to the relevant sections including in the Materials and methods section. We have also provided data in Figure 6 demonstrating that the HGA susceptibility and resistance phenotypes in the rich media and PBS assays are robust across different inoculum growth stages.

> \- Ecological relevance seems more asserted than supported by data. Where has HGA been shown to be important?

We agree with this criticism and have now re-focused the Discussion section to focus more on our findings and more clearly separate where we are speculating on the possible ecological implications.

> \- Discussion section is overly speculative and unfocused.

We agree with this criticism. We have now completely re-written the Discussion section to make it more focused in light of suggestions made by the reviewers. We have also amended the title of our paper to focus on the chief findings of our paper rather than on our speculation about its ecological implications, which we have considerably revised in the Discussion section.

> Reviewer \#2:
>
> Levin and colleagues identified a new activity of a pigment produced by Legionella -- a redox-sensitive inhibition of growth. By applying a logical series of genetic and biological assays, they also identified a previously uncharacterized locus that modulates bacterial sensitivity to the HGA pigment. The authors discuss their results within a provocative ecological framework, proposing that, by secreting the pigment in stationary phase, L. pneumophila restricts encroachment by competitor Legionella.
>
> In general, the experiments are logical, quantitative, and well controlled, and the primary conclusions are supported by data provided. The value of the manuscript is to advance the scant literature on mechanisms of ecological fitness of L. pneumophila in aquatic environments, the source of transmission to humans.

We thank reviewer \#2 for her positive comments.

> Ambiguity concerning growth phase vs cell density complicates independent interpretation and replication of the results, a weakness that can be corrected by editing and/or comparing directly log and stationary phase WT cells in their HGA-sensitivity assay.

We thank the reviewer for her feedback and for the detailed suggestions. In keeping with these comments, we have now performed several additional experiments which we now summarize in Figure 6 in the revised version. These experiments decouple the growth phase from cell density, showing that resistance to HGA inhibition is both cell-intrinsic (see below), density-dependent, and independent of growth phase.

> 1\) Cell density vs growth phase: Abstract, Results section, Discussion section; Figure 4, Figure 5, Figure 4---figure supplement 1 and elsewhere. L. pneumophila induce expression of multiple virulence and resilience traits upon entry into stationary phase, whereas exponential phase cells are more susceptible to killing by macrophages and a variety of environmental stresses (e.g. Molofsky and Swanson, 2004; Olivia et al., 2018). Accordingly, in experiments testing sensitivity of Legionella to HGA, clarify in Materials and methods section and relevant figure legends the growth phase of the cells that were challenged with HGA. Currently, the references to \"regulatory state\" (Discussion section) are vague and not tested directly here.

We thank the reviewer for these suggestions and citations. We have now added details about the cultures used to set up our experiments in the Materials and methods section. More importantly, we have added several new experiments in Figure 6 to show that across our assays, cell sensitivity to HGA correlates with cell density and does not depend on the growth phase of the inoculum.

> 2\) HGA induces transient \"growth delay\", Figure 4, Figure 5, Figure 4---figure supplement 1, Figure 5---figure supplement 2, and Results section \"improvement in growth\": Without knowing the growth phase of inocula used throughout this study, it is difficult to interpret the apparent prolonged lag phase of HGA-treated cells: Does HGA kill a large subset of the treated population, or instead delay entrance into the cell cycle for the entire population? If the latter, do you speculate that HGA loses activity or instead that the bacteria adapt to overcome the HGA block to replication?

These are excellent points raised by the reviewer, which we now address in detail in the revision with several new experiments. In new Figure 4 and Figure 4---figure supplement 1, we now show multiple lines of evidence that HGA in rich media is bacteriostatic instead of bacteriocidal against *Lp*, and that the basis of recovery from the growth delay is not via genetic adaptation. Instead, multiple lines of evidence lead us to conclude that HGA auto-oxidation in rich media over time negates its inhibitory effects, and that *Lp* bacterial cells are able to recover and resume growth after HGA concentrations drop below inhibitory levels.

> 3 Cell density protection, Figure 4D, Figure 4---figure supplement 1, and Results section: Do cells need to be metabolically active to confer protection from HGA, or is this a biochemical effect of distributing the oxidative damage across more substrate -- more surface area of stationary phase L. pneumophila cells? For example, do UV-inactivated bacteria protect a minority population of viable stationary phase cells? Related to \#1, at high densities, are log phase cells also protected from HGA treatment?

We thank the reviewer for these thoughtful suggestions, which we have gratefully used to motivate and perform new experiments. First, we show that in the PBS assay, both log and stationary phase cells are protected from HGA at high densities, but susceptible at low densities (new Figure 6C). We also find that high-density, heat-killed bacteria do not protect low-density live bacteria from HGA, suggesting that protection is not merely from abundant surface area or substrate (Figure 7---figure supplement 1A). Finally, we find that the conditioned media from high-density cells exposed to HGA retains the activity to kill low-density cells, showing that the HGA is not inactivated or adsorbed out of solution in high-density conditions (Figure 6E). Based on these experiments, we conclude that high-density protection is a cell-intrinsic effect, rather than a biochemical one of HGA dilution or distribution across more cells.

> 4\) Title and Discussion section, \"observed specificity\": Whether HGA also inhibits non-Legionella bacteria is predicted from the Stewart et al., 2011 study of surfactant and implied here but is not tested directly. Also, this paragraph focuses on pigments, but cites Stewart et al., 2011 that only analyzes surfactant.

Yes, we agree with this point. We have rephrased these sections to be more precise, and removed this section from the revised, refocused Discussion section.

> 5\) Translation mutants alter HGA susceptibility, Results section: Nam et al., 2016 reported that disruption of elongation factor P function induces the stringent response of Salmonella. Since the stringent response triggers entry of replicating L. pneumophila into stationary phase and the more resilient \"transmissive\" cell type (eg Molofsky and Swanson, 2004; Olivia et al., 2018), the authors may wish to comment on whether activation of the stringent response might account for the isolation of a large number of translation mutants in the screen for enhanced resistance to HGA.

We agree with the reviewer's suggestion. We had not fully explored the potential link between elongation factor P and *Legionella's* stringent response in our previous manuscript. We now discuss the stringent response in light of our resistant mutant screen. We also perform experiments with *Lp* bacteria strains with mutations in the stringent response pathway. However, we find that these mutations do not appear to alter HGA susceptibility or high-density resistance (Figure 7---figure supplement 1C-D). In the discussion, we note that the resistant mutants we have recovered in our screen show only partial resistance to HGA (Figure 5). Therefore, it is possible that high-density cells are able to fully resist HGA via another mechanism.

> Reviewer \#3:
>
> Levin et al. identify an important mechanism that Legionella pneumophila may employ to successfully compete in complex multispecies communities. Specifically, demonstrate that interbacterial competition between closely related Legionella species is mediated in part by the secretion of the inhibitory molecule homogentisic acid by L. pneumophila. This work is important as it reveals a novel mechanism this pathogen may use to thrive in the environment. They identify HGA as the inhibitory molecule using a random transposon mutagenesis approach and further characterize mutations that increase resistance to HGA in the producing strain. Cysteine is shown to protect cells from the toxic effects of HGA and the oxidized form of the molecule (HGA-melanin) is non-toxic, suggesting that redox activity of HGA is important for the mechanism of inhibition. The work is well done, and the manuscript is well written.

We thank the reviewer for their generous comments!

\[Editors\' note: the author responses to the re-review follow.\]

> Overall, you have done an outstanding job in responding to the first set of reviews, and this manuscript is on-track for acceptance in eLife. However, the reviewers made a few suggestions that are constructive, which you will likely want to incorporate into your final manuscript prior to publication. The goal here is to help you polish your work one last time, but not to add onerous new experiments. No additional new experimentation is required, but should you want to try one quick experiment independently suggested by reviewer 1 and reviewer 3, please go for it.
>
> We look forward to receiving your final revised manuscript and processing it for publication shortly!

Thank you very much! We have elected to perform this experiment and discuss its new results below.

> Reviewer \#1:
>
> \[...\] The experiments with cysteine and transposon mutagenesis point toward disruption of disulfide bonds and/or cysteine reactivity as plausible mechanisms of toxicity (even if not the only mechanisms). One straightforward experiment that might be helpful in testing whether oxidative intermediates are responsible for HGA toxicity would be for the authors to expose the cells to HGA under anoxic conditions, followed by a wash and plating under oxic conditions (in comparison to exposure and plating under oxic conditions).

Thank you to both reviewer 1 and reviewer 3 for the great suggestion. We have now performed this experiment, exposing *L. pneumophila* to HGA in both aerobic and anaerobic conditions. Instead of doing a wash, we immediately diluted the samples to plate CFUs in rich media, which we reasoned would dilute and/or inactivate the HGA below an active concentration. We found that HGA had little to no toxicity under anaerobic conditions, suggesting that the toxicity is indeed due to some of HGA's transient oxidative intermediates. The results are now included in Figure 7B, and discussed briefly in the text.

> Reviewer \#3:
>
> Levin et al., have modified their previous manuscript in response to earlier reviews. The focus is narrowed to highlight the role of HGA in inhibiting Legionella spp. and that resistance to this inhibition is density dependent the producing species, Lp. This inhibition is shown to be independent of secreted surfactants, disproving a hypothesis previously set forth in the field. The secreted inhibitory factor is identified as HGA using a clever genetic screen for transposon mutants, and HGA is later shown to be inhibitory at biologically relevant concentrations. They show that this inhibitory activity is due to HGA and that catalase was not protective suggesting that inhibition is not due to the production of H2O2 through side reactions. They further show evidence that HGA inhibition is bacteriostatic rather than bacteriocidal in Lp and perform a forward genetic selection to identify genes that allow for growth in the presence of HGA. Unsurprisingly, they identify many genes that likely have global effects, and focus on one gene that was mutated in a subset of the population. The authors speculate that periplasmic disulfide bond formation may be important to mediate the cellular response to HGA, but no direct evidence is given. This resistance response may be density, but not growth phase, dependent and cell-intrinsic.

We appreciate the reviewer's summary and appreciation for the work. We also agree that we have not definitively proved that HGA toxicity occurs via periplasmic disulfide bond disruption. This speculation was intended to help motivate future, follow-up work. We have modified the language in the Discussion section to make this distinction more clear.

> Several new experiments strengthen this version of the manuscript and address many questions raised previously. While the authors are unable to identify a mechanism by which HGA inhibits cells or LP gains resistance, many \"obvious\" candidates are tested and determined to not play a role and it is likely that resistance mechanisms will have global cellular effects that are difficult to tease apart. This is an interesting first observation of the phenomenon and should be of interest to a broad group of scientists.

Thank you, we agree that the phenomenon is interesting and striking.

[^1]: Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States.
